52 days until earnings call
Interact to see
Advertisement
Advertisement
GINX vs NVS
GINX vs NVS Comparison
Open Charts GINX vs NVS
SGI Enhanced Global Income ETF
Price$29.21
Change+$0.04 (+0.14%)
Volume$3.53K
Net Assets83.26M
Novartis AG
Price$129.73
Change+$1.31 (+1.02%)
Volume$1.34M
Capitalization250.37B
GINX vs NVS Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
GINX vs. NVS commentary
Sep 06, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GINX is a Hold and NVS is a Buy.
SUMMARIES
FUNDAMENTALS RATINGS
NVS: Fundamental Ratings
NVS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 11 | |
SMR RATING 1..100 | 29 | |
PRICE GROWTH RATING 1..100 | 48 | |
P/E GROWTH RATING 1..100 | 80 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| GINX | NVS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 40% | 1 day ago 38% |
| Stochastic ODDS (%) | 1 day ago 60% | 1 day ago 37% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 49% |
| MACD ODDS (%) | 1 day ago 63% | 1 day ago 52% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 49% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 46% |
| Advances ODDS (%) | 1 day ago 88% | 1 day ago 49% |
| Declines ODDS (%) | 3 days ago 59% | N/A |
| BollingerBands ODDS (%) | 1 day ago 58% | 1 day ago 32% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 41% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
GINX and
Correlation & Price change
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
|---|---|---|---|---|
| GINX | 100% | +0.15% | ||
| GSK - GINX | 24% Poorly correlated | +2.25% | ||
| RELX - GINX | 21% Poorly correlated | +0.53% | ||
| KMB - GINX | 21% Poorly correlated | +1.55% | ||
| NVS - GINX | 20% Poorly correlated | +1.02% | ||
| KO - GINX | 20% Poorly correlated | -0.42% | ||
More | ||||
NVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, NVS has been closely correlated with GSK. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVS jumps, then GSK could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y